Skip to content

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01317654
Acronym
ES
Enrollment
340
Registered
2011-03-17
Start date
2006-04-30
Completion date
2008-04-30
Last updated
2011-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis Meningitis

Keywords

Tuberculosis meningitis

Brief summary

All patients who were alive at the end of the dexamethasone treatment trial conducted by Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to participate in this long-term follow-up study. All eligible and consenting patients will undergo an assesment consisting of a simple questionnaire, a clinical examination and a blood test. Data collected will focus on survival, neurological disability and tuberculosis relapse. Data will be collected in individual case record forms and entered into a computer database.

Interventions

OTHERObservation

Collection of mortality data at 5 years post trial

Sponsors

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
CollaboratorOTHER
Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
CollaboratorOTHER
Oxford University Clinical Research Unit, Vietnam
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Patients were alive at the end of the dexamethasone study (n=340) will be eligible to participate in this long-term follow-up study Informed consent

Exclusion criteria

Patients without informed consent

Design outcomes

Primary

MeasureTime frame
Survival5 years

Secondary

MeasureTime frame
Neurological disability5 years
Tuberculosis relapse rate5 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026